Volume 13, Issue 5, Pages (May 2012)

Slides:



Advertisements
Similar presentations
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Estrogen Plus Progestin and Breast Cancer Incidence.
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 14, Issue 12, Pages (November 2013)
Volume 387, Issue 10037, Pages (June 2016)
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Volume 364, Issue 9440, Pages (September 2004)
Volume 367, Issue 9517, Pages (April 2006)
Volume 376, Issue 9747, Pages (October 2010)
Volume 16, Issue 9, Pages (September 2015)
Volume 373, Issue 9660, Pages (January 2009)
Volume 388, Issue 10058, Pages (November 2016)
Volume 15, Issue 6, Pages (May 2014)
Volume 376, Issue 9734, Pages (July 2010)
Volume 17, Issue 2, Pages (February 2016)
The benefits and harms of breast cancer screening
San Antonio Breast Cancer Symposium, December 6-10, 2016
Volume 19, Issue 2, Pages (February 2018)
Meta-analysis of randomised controlled trials
Volume 389, Issue 10076, Pages (April 2017)
Intraoperative radiotherapy for early breast cancer
Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation.
Volume 376, Issue 9734, Pages (July 2010)
Volume 9, Issue 5, Pages (May 2008)
Volume 13, Issue 3, Pages (March 2012)
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Volume 15, Issue 4, Pages (April 2014)
Contribution of risk factors to excess mortality in isolated and lonely individuals: an analysis of data from the UK Biobank cohort study  Prof Marko.
Volume 373, Issue 9677, Pages (May 2009)
Effects of community health interventions on under-5 mortality in rural Guinea-Bissau (EPICS): a cluster-randomised controlled trial  Dr Peter Boone,
Aspirin in the prevention of cancer – Author's reply
Volume 374, Issue 9707, Pages (December 2009)
Volume 13, Issue 11, Pages (November 2012)
Volume 372, Issue 9642, Pages (September 2008)
Volume 9, Issue 10, Pages (October 2008)
Volume 12, Issue 7, Pages (July 2011)
Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study  Nabihah Sachedina, MBBS, Prof.
Volume 375, Issue 9732, Pages (June 2010)
Volume 379, Issue 9812, Pages (January 2012)
Mortality in single fathers compared with single mothers and partnered parents: a population-based cohort study  Maria Chiu, PhD, Farah Rahman, MPH, Simone.
Volume 14, Issue 6, Pages (May 2013)
Volume 373, Issue 9660, Pages (January 2009)
Volume 14, Issue 11, Pages (October 2013)
Volume 18, Issue 3, Pages (March 2017)
Volume 372, Issue 9647, Pages (October 2008)
Volume 388, Issue 10058, Pages (November 2016)
Volume 371, Issue 9627, Pages (May 2008)
Volume 378, Issue 9786, Pages (July 2011)
Volume 2, Issue 5, Pages (May 2015)
Volume 9, Issue 4, Pages (April 2008)
Volume 383, Issue 9922, Pages (March 2014)
Volume 5, Issue 4, Pages (April 2018)
Volume 375, Issue 9726, Pages (May 2010)
Volume 373, Issue 9658, Pages (January 2009)
Volume 375, Issue 9719, Pages (March 2010)
Volume 19, Issue 2, Pages (February 2018)
Volume 15, Issue 6, Pages (May 2014)
Insulin-like growth factor-l and risk of breast cancer
ACST: which subgroups will benefit most from carotid endarterectomy?
Volume 11, Issue 3, Pages (March 2010)
Volume 381, Issue 9871, Pages (March 2013)
Volume 371, Issue 9618, Pages (March 2008)
Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled.
Steven A Narod  The Lancet  Volume 349, Issue 9068, (June 1997)
Volume 376, Issue 9747, Pages (October 2010)
Effect of a behaviour change intervention on the quality of peri-urban sanitation in Lusaka, Zambia: a randomised controlled trial  James B Tidwell, PhD,
Volume 12, Issue 1, Pages (January 2011)
Volume 378, Issue 9809, Pages (December 2011)
Volume 14, Issue 7, Pages (June 2013)
Volume 17, Issue 2, Pages (February 2016)
Presentation transcript:

Volume 13, Issue 5, Pages 476-486 (May 2012) Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial  Prof Garnet L Anderson, PhD, Prof Rowan T Chlebowski, MD, Aaron K Aragaki, MS, Prof Lewis H Kuller, MD, Prof JoAnn E Manson, MD, Prof Margery Gass, MD, Elizabeth Bluhm, MD, Prof Stephanie Connelly, MD, Prof F Allan Hubbell, MD, Prof Dorothy Lane, MD, Lisa Martin, MD, Prof Judith Ockene, PhD, Prof Thomas Rohan, MBBS, Prof Robert Schenken, MD, Prof Jean Wactawski-Wende, PhD  The Lancet Oncology  Volume 13, Issue 5, Pages 476-486 (May 2012) DOI: 10.1016/S1470-2045(12)70075-X Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 1 Kaplan-Meier estimates of cumulative hazards of invasive breast cancer in the WHI randomised trial of conjugated equine oestrogen with the intention-to-treat principle (A) and with adjustments for adherence (B) Background shading shows the distribution of the duration of intervention (in quintiles). HR=hazard ratio. The Lancet Oncology 2012 13, 476-486DOI: (10.1016/S1470-2045(12)70075-X) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 2 Kaplan-Meier estimates of cumulative hazards for breast cancer deaths (A) and all-cause mortality after breast cancer (B) in the WHI randomised trial of conjugated equine oestrogen Background shading shows the distribution of the duration of intervention (in quintiles). HR=hazard ratio. The Lancet Oncology 2012 13, 476-486DOI: (10.1016/S1470-2045(12)70075-X) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 3 Hazard ratios for invasive breast cancer incidence by baseline characteristics in the WHI trial of conjugated equine oestrogen Data are n (% per year) unless otherwise stated. The Lancet Oncology 2012 13, 476-486DOI: (10.1016/S1470-2045(12)70075-X) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 4 Cumulative hazards, adjusted for age and ethnic group, of invasive breast cancer by random allocation in the WHI trials of conjugated equine oestrogen alone and conjugated equine oestrogen plus medroxyprogesterone acetate trials derived from Chlebowski and colleagues32 HR=hazard ratio. The Lancet Oncology 2012 13, 476-486DOI: (10.1016/S1470-2045(12)70075-X) Copyright © 2012 Elsevier Ltd Terms and Conditions